| Rachel B Tarmy, PA | |
|
1 Medical Center Dr, Biddeford, ME 04005-9422 | |
| (207) 283-7937 | |
| (207) 283-7275 |
| Full Name | Rachel B Tarmy |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 13 Years |
| Location | 1 Medical Center Dr, Biddeford, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194004341 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | PA-287 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southern Maine Health Care | Biddeford, ME | Hospital |
| Maine Medical Center | Portland, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mainehealth | 7517860588 | 2067 |
| Maine Medical Partners | 9335043967 | 789 |
News Archive
Fear and confusion surrounding the diagnosis is often the result of suffering of antibiotic-resistant bacteria. Accurate information is crucial for these patients in order for them to handle their situation, yet that is the area where health care is lacking.
While the development of therapies designed to block "checkpoints" within the immune system has been one of the most exciting and noteworthy advances in cancer research in recent years, it's also been one of the most puzzling, leaving researchers to ask: Why don't these new therapies work for more patients, and why is their efficacy in controlling cancerous tumors often short-lived? A research team from Roswell Park Cancer Institute has shown that at least one answer -; and an excellent opportunity for unleashing the full potential of these promising immunotherapies -; may lie in the body's "fight or flight" reaction to stressors and in drugs already widely used to control and temporarily disable this stress response.
United Therapeutics Corporation and Lee's Pharmaceutical Holdings Ltd. announced today that they have entered into an exclusive agreement for the distribution of Remodulin (treprostinil) Injection in China. Remodulin is a subcutaneously or intravenously administered prostacyclin analogue for the treatment of pulmonary arterial hypertension. Lee's Pharmaceutical is a leading Chinese pharmaceutical company with both a strong cardiovascular focus and extensive commercialization experience.
Research published today (Feb. 11, 2019) reveals how one mutation causes fragile X, the most common inherited intellectual disability.
New research published online in the journal Substance Use & Misuse is good news for those struggling with alcohol dependence: the possibility of ending this dependency gets easier with age.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel B Tarmy, PA 1 Medical Center Dr, Biddeford, ME 04005-9422 Ph: (207) 283-7937 | Rachel B Tarmy, PA 1 Medical Center Dr, Biddeford, ME 04005-9422 Ph: (207) 283-7937 |
News Archive
Fear and confusion surrounding the diagnosis is often the result of suffering of antibiotic-resistant bacteria. Accurate information is crucial for these patients in order for them to handle their situation, yet that is the area where health care is lacking.
While the development of therapies designed to block "checkpoints" within the immune system has been one of the most exciting and noteworthy advances in cancer research in recent years, it's also been one of the most puzzling, leaving researchers to ask: Why don't these new therapies work for more patients, and why is their efficacy in controlling cancerous tumors often short-lived? A research team from Roswell Park Cancer Institute has shown that at least one answer -; and an excellent opportunity for unleashing the full potential of these promising immunotherapies -; may lie in the body's "fight or flight" reaction to stressors and in drugs already widely used to control and temporarily disable this stress response.
United Therapeutics Corporation and Lee's Pharmaceutical Holdings Ltd. announced today that they have entered into an exclusive agreement for the distribution of Remodulin (treprostinil) Injection in China. Remodulin is a subcutaneously or intravenously administered prostacyclin analogue for the treatment of pulmonary arterial hypertension. Lee's Pharmaceutical is a leading Chinese pharmaceutical company with both a strong cardiovascular focus and extensive commercialization experience.
Research published today (Feb. 11, 2019) reveals how one mutation causes fragile X, the most common inherited intellectual disability.
New research published online in the journal Substance Use & Misuse is good news for those struggling with alcohol dependence: the possibility of ending this dependency gets easier with age.
› Verified 5 days ago
Sara Fix, Physician Assistant Medicare: Medicare Enrolled Practice Location: 9 Healthcare Dr Ste 202, Biddeford, ME 04005 Phone: 207-283-1427 | |
Zorica Bajic, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 9 Healthcare Dr, Suite 204, Biddeford, ME 04005 Phone: 207-283-1427 | |
Timothy Lens, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7000 | |
Mrs. Tamsen Howes, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7931 | |
Bethany A Smith, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7937 Fax: 207-283-7018 | |
Beth Jane Hart, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 26 W Cole Rd Ste 102, Biddeford, ME 04005 Phone: 207-294-5800 | |
Angela Martel, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 46 Barra Road, Suites 201/202, Biddeford, ME 04005 Phone: 207-282-3349 |